548 related articles for article (PubMed ID: 30668781)
1. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
2. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis.
Wong CKH; Chen JY; Fung SKS; Lo WK; Lui SL; Chan TM; Cheng YL; Kong I; Wan EYF; Lam CLK
Nephrology (Carlton); 2019 Jun; 24(6):630-637. PubMed ID: 29926521
[TBL] [Abstract][Full Text] [Related]
4. An operating cost comparison between conventional and home quotidian hemodialysis.
Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM
Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444
[TBL] [Abstract][Full Text] [Related]
5. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
6. Home Dialysis Is Associated with Lower Costs and Better Survival than Other Modalities: A Population-Based Study in Ontario, Canada.
Krahn MD; Bremner KE; de Oliveira C; Dixon SN; McFarlane P; Garg AX; Mitsakakis N; Blake PG; Harvey R; Pechlivanoglou P
Perit Dial Int; 2019; 39(6):553-561. PubMed ID: 31582466
[No Abstract] [Full Text] [Related]
7. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
[TBL] [Abstract][Full Text] [Related]
10. The cost of renal dialysis in a UK setting--a multicentre study.
Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations.
Walker R; Marshall MR; Morton RL; McFarlane P; Howard K
Nephrology (Carlton); 2014 Aug; 19(8):459-70. PubMed ID: 24750559
[TBL] [Abstract][Full Text] [Related]
12. Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan.
Tang CH; Chen HH; Wu MJ; Hsu BG; Tsai JC; Kuo CC; Lin SP; Chen TH; Sue YM
BMJ Open; 2019 Mar; 9(3):e023062. PubMed ID: 30904836
[TBL] [Abstract][Full Text] [Related]
13. A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.
de Abreu MM; Walker DR; Sesso RC; Ferraz MB
Perit Dial Int; 2013; 33(3):304-15. PubMed ID: 23209041
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
15. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
16. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
Liu FX; Treharne C; Culleton B; Crowe L; Arici M
BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
[TBL] [Abstract][Full Text] [Related]
17. A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.
Makhele L; Matlala M; Sibanda M; Martin AP; Godman B
Pharmacoecon Open; 2019 Dec; 3(4):631-641. PubMed ID: 30868410
[TBL] [Abstract][Full Text] [Related]
18. Financial implications of dialysis modalities in the developing world: A Chinese perspective.
Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P
Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196
[TBL] [Abstract][Full Text] [Related]
19. Cost analysis of renal replacement therapies in Finland.
Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
[TBL] [Abstract][Full Text] [Related]
20. PD vs HD in Post-Economic Crisis Greece-Differences in Patient Characteristics and Estimation of Therapy Cost.
Koukou MG; Smyrniotis VE; Arkadopoulos NF; Grapsa EI
Perit Dial Int; 2017; 37(5):568-573. PubMed ID: 28698249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
